Dronedarone

CHEMBL184412 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
556.8 g/mol
LogP
7.2
Phase
4

An antiarrhythmic medication used to reduce the risk of hospitalization in patients with atrial fibrillation or atrial flutter. It works by blocking multiple ion channels in the heart to maintain normal rhythm.

الوزن الجزيئي

556,8000 g/mol

LogP

7,20

TPSA

97,20 Ų

قاعدة ليبينسكي للخمسة

راسب

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1

InChI

InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3

Molecular Formula

C31H44N2O5S

HBD / HBA

1 / 7

الروابط القابلة للدوران

18

الذرات الثقيلة

39

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

An antiarrhythmic medication used to reduce the risk of hospitalization in patients with atrial fibrillation or atrial flutter. It works by blocking multiple ion channels in the heart to maintain normal rhythm.

Yes, Dronedarone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL184412. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 208898. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.